Andy Cooper

Andy holds a degree in Pharmacology from the University of Leeds, UK, where his final year was focused on data mining the human genome for undiscovered inwardly rectifying potassium channels. This ignited Andy’s passion for applying software to address data challenges in drug development. Andy has spent the past 20+ years working at software companies to provide solutions that enable global Clinical Operations, Clinical Data Management, and Pharmacovigilance business processes. Andy joined CluePoints in December 2022 and serves as the Chief Executive Officer.